Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now indicates recruitment is closed to new participants, and new help-related sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, alongside a minor formatting change to the Intervention/Treatment label and removal of the prior revision note.
    Difference
    0.4%
    Check dated 2026-06-12T15:38:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor behind-the-scenes update to the site's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T10:06:12.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.5.4, signaling a newer release of the site. This update does not alter the displayed study details or navigation.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:29.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page metadata shows an interface/release revision bump from v3.5.2 to v3.5.3, with no changes to the underlying ClinicalTrials.gov study content.
    Difference
    0.0%
    Check dated 2026-04-23T21:57:20.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T12:16:24.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Update of the Italy location entry from Padua, Italy, 35128 to Padova, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T09:28:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.